Fig. 3: BLI kinetic assays of the designed peptides binding to the receptor IL-10Ra. | Communications Chemistry

Fig. 3: BLI kinetic assays of the designed peptides binding to the receptor IL-10Ra.

From: A peptide derived from interleukin-10 exhibits potential anticancer activity and can facilitate cell targeting of gold nanoparticles loaded with anticancer therapeutics

Fig. 3

Wavelength shift curves show the association and dissociation of the designed peptides (a) NM25, (b) NK20, (c) NK20a, (d) CG20 binding to the IL-10 receptor, and (e) NK20a binding to a control receptor IL-1R1 at various concentrations. Dissociation was recorded at 120 s after the binding started (black dotted line).

Back to article page